Medicare Part D (Prescription Drug) Plans May Now Cover Omnipod®
Significantly Expands Access to Omnipod and
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180108005635/en/
“We are incredibly excited about CMS’ confirmation that Omnipod is eligible for coverage under Medicare Part D, which allows many additional people living with diabetes to benefit from Omnipod’s freedom and ease of use,” said
“On behalf of the diabetes community, we are pleased that Insulet’s revolutionary Omnipod technology will now be available to those with Medicare Part D coverage,” said
The CMS guidance empowers
“Access to appropriate technology is paramount for people living with diabetes and is a key priority for our organization,” said
The Company will provide its 2018 financial guidance in connection with announcing fourth quarter 2017 financial results in
About
*Starting
Forward-Looking Statement:
This press release may contain forward-looking statements concerning Insulet's expectations, anticipations, intentions, beliefs or strategies regarding the future. These forward-looking statements are based on its current expectations and beliefs concerning future developments and their potential effects on Insulet. There can be no assurance that future developments affecting Insulet will be those that it has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond its control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, and other risks and uncertainties described in its Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on February 28, 2017 in the section entitled "Risk Factors," and in its other filings from time to time with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of its assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Insulet undertakes no obligation to publicly update or revise any forward-looking statements.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180108005635/en/
Vice President, Investor Relations and Corporate Communications
[email protected]
Source:
EDITORIAL: Replacing money in court clerk’s office right move
Insurers Leverage New Technologies and Reinvent Business Models to Reach Underserved Consumers, Report Finds
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News